📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Identification of pathways to high-level vancomycin resistance in Clostridioides difficile that incur high fitness costs in key pathogenicity traits. (2024)

First Author: Buddle JE

Attributed to: Does CRISPR-Cas immunity limit the effectiveness of phage therapy? funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pbio.3002741

PubMed Identifier: 39146240

Publication URI: http://europepmc.org/abstract/MED/39146240

Type: Journal Article/Review

Volume: 22

Parent Publication: PLoS biology

Issue: 8

ISSN: 1544-9173